𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Relationships between biochemical markers of bone and cartilage degradation with radiological progression in patients with knee osteoarthritis receiving risedronate: the Knee Osteoarthritis Structural Arthritis randomized clinical trial

✍ Scribed by P. Garnero; W.S. Aronstein; S.B. Cohen; P.G. Conaghan; G.A. Cline; C. Christiansen; J.F. Beary; J.M. Meyer; C.O. Bingham III

Book ID
113732712
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
214 KB
Volume
16
Category
Article
ISSN
1063-4584

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Risedronate decreases biochemical marker
Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: Results of the two-year multinational knee osteoarthritis structural arthritis study
✍ Clifton O. Bingham III; J. Chris Buckland-Wright; Patrick Garnero; Stanley B. Co πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 228 KB πŸ‘ 2 views

## Abstract ## Objective Bisphosphonates have slowed the progression of osteoarthritis (OA) in animal models and have decreased pain in states of high bone turnover. The Knee OA Structural Arthritis (KOSTAR) study, which is the largest study to date investigating a potential structure‐modifying OA